Kimialys,
since 2020
5 years of expert services in biosensing
In a nutshell:
Kimialys is an innovative industrial company specialized in biosensing, enabling laboratories worldwide to develop and produce tomorrow’s diagnostics and therapeutics. With over 100 projects delivered on complex real-world applications, we are contributing to the most innovative biotherapies and assays under development.
K-One is Kimialys’ proprietary technology, a surface chemistry that powers all our products and services today. It is a self-assembled monolayer (SAM) optimized for gold nanoparticles, chips, and electrodes, unlocking applications once out of reach due to technological limitations, and setting new standards in biosensing: detection, extraction, screening, characterization.
By combining K-One with our expertise in ligand functionalization, nanoparticle- and chip-based assays, as well as biosensors, we enable advanced applications in diagnostic development, drug discovery, bioanalysis, and are a partner of choice for AI-driven biomolecule design teams. Our approach enhances key assay parameters, such as sensitivity, specificity, selectivity, reproducibility, and cost-effectiveness, without ever compromising one for another.
